Paranasal sinus squamous cell carcinoma incidence and survival based on surveillance, epidemiology, and end results data, 1973 to 2009

Cancer

Volumn 119, Issue 14, 2013, Pages 2602-2610

  Ansa, Benjamin ^a   Goodman, Michael ^b   Ward, Kevin ^b   Kono, Scott A ^c   Owonikoko, Taofeek K ^c   Higgins, Kristin ^c   Beitler, Jonathan J ^c   Grist, William ^c   Wadsworth, Trad ^c   El Deiry, Mark ^c   Chen, Amy Y ^c   Khuri, Fadlo Raja ^c   Shin, Dong M ^c   Saba, Nabil F ^c  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

incidence and survival of sinonasal cancers; paranasal sinus; squamous cell carcinoma

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; ETHNIC GROUP; FEMALE; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; PARANASAL SINUS CARCINOMA; PARANASAL SINUS SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; SEX; SQUAMOUS CELL CARCINOMA; SURVEILLANCE EPIDEMIOLOGY AND END RESULTS PROGRAM;

INCIDENCE AND SURVIVAL OF SINONASAL CANCERS; PARANASAL SINUS; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; ETHMOID SINUS; FEMALE; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MAXILLARY SINUS NEOPLASMS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PARANASAL SINUS NEOPLASMS; SEER PROGRAM; SURVIVAL RATE; UNITED STATES;

EID: 84879684221     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28108     Document Type: Article

References (24)

1. Norlander T, Frodin J, Silfversward C, Anggard A,. Decreasing incidence of malignant tumors of the paranasal sinuses in Sweden. An analysis of 141 consecutive cases at Karolinska Hospital from 1960 to 1980. Ann Otol Rhinol Laryngol. 2003; 112: 236-241.
2. Harbo G, Grau C, Bundgaard T, et al. Cancer of the nasal cavity and paranasal sinuses. A clinico-pathological study of 277 patients. Acta Oncol. 1997; 36: 45-50.
3. Grau C, Jakobsen MH, Harbo G, et al. Sino-nasal cancer in Denmark 1982-1991-a nationwide survey. Acta Oncol. 2001; 40: 19-23.
4. Thorup C, Sebbesen L, Dano H, et al. Carcinoma of the nasal cavity and paranasal sinuses in Denmark 1995-2004. Acta Oncol. 2010; 49: 389-394.
5. Osguthorpe JD,. Sinus neoplasia. Arch Otolaryngol Head Neck Surg. 1994; 120: 19-25.
6. Carrau RL, Myers EM, Johnson JT,. Paranasal sinus carcinoma-diagnosis, treatment, and prognosis. Oncology (Williston Park). 1992; 6: 43-50.
7. Katz TS, Mendenhall WM, Morris CG, Amdur RJ, Hinerman RW, Villaret DB,. Malignant tumors of the nasal cavity and paranasal sinuses. Head Neck. 2002; 24: 821-829.
8. Mehra YN, Mann SB, Dubey SP, Suri S,. Computed tomography for determining pathways of extension and a staging and treatment system for juvenile angiofibromas. Ear Nose Throat J. 1989; 68: 576-589.
9. Waldron J, Witterick I,. Paranasal sinus cancer: caveats and controversies. World J Surg. 2003; 27: 849-855.
10. Myers LL, Nussenbaum B, Bradford CR, Teknos TN, Esclamado RM, Wolf GT., Paranasal sinus malignancies: an 18-year single institution experience. Laryngoscope. 2002; 112: 1964-1969.
11. Roush GC,. Epidemiology of cancer of the nose and paranasal sinuses: current concepts. Head Neck Surg. 1979; 2: 3-11.
12. Luce D, Leclerc A, Begin D, et al. Sinonasal cancer and occupational exposures: a pooled analysis of 12 case-control studies. Cancer Causes Control. 2002; 13: 147-157.
13. d'Errico A, Pasian S, Baratti A, et al. A case-control study on occupational risk factors for sino-nasal cancer. Occup Environ Med. 2009; 66: 448-455.
14. Bhattacharyya N,. Factors affecting survival in maxillary sinus cancer. J Oral Maxillofac Surg. 2003; 61: 1016-1021.
15. Hayes RB, Kardaun JW, de Bruyn A,. Tobacco use and sinonasal cancer: a case-control study. Br J Cancer. 1987; 56: 843-846.
16. National Cancer Institute. Surveillance, Epidemiology, and End Results Program. Available at: http://seer.cancer.gov. [Accessed April 2, 2013].
17. Tiwari RC, Clegg LX, Zou Z,. Efficient interval estimation for age-adjusted cancer rates. Stat Methods Med Res. 2006; 16: 547-569.
18. Kleinbaum DG,. Survival Analysis: A Self-Learning Text. New York: Springer-Verlag; 1995.
19. Lewis JS, Castro EB,. Cancer of the nasal cavity and paranasal sinuses. J Laryngol Otol. 1972; 86: 255-262.
20. Turner JH, Reh D,. Incidence and survival in patients with sinonasal cancer: a historical analysis of population-based data. Head Neck. 2012; 34: 877-885.
21. Ellington CL, Goodman M, Kono SA, et al. Adenoid cystic carcinoma of the head and neck: incidence and survival trends based on 1973-2007 Surveillance, Epidemiology, and End Results data. Cancer. 2012; 118: 4444-4451.
22. Saba NF, Goodman M, Ward K, et al. Gender and ethnic disparities in incidence and survival of squamous cell carcinoma of the oral tongue, base of tongue, and tonsils: a Surveillance, Epidemiology and End Results program-based analysis. Oncology. 2011; 81: 12-20.
23. Ludwig MS, Goodman M, Miller DL, Johnstone PA,. Postoperative survival and the number of lymph nodes sampled during resection of node-negative non-small cell lung cancer. Chest. 2005; 128: 1545-1550.
24. Esiashvili N, Goodman M, Marcus RB Jr,. Changes in incidence and survival of Ewing sarcoma patients over the past 3 decades: Surveillance Epidemiology and End Results data. J Pediatr Hematol Oncol. 2008; 30: 425-430.